翰宇药业 (300199.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(翰宇药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
关 闭
完整财报对比
2020年中报2020年一季报2019年年报2019年三季报2019年中报2019年一季报2018年年报2018年三季报2018年中报2018年一季报
主要指标:
 营业收入(元) 440,147,161.56191,822,242.88614,191,475.23556,778,667.69450,715,436.29192,837,994.711,264,444,507.22905,037,196.30646,871,459.48268,644,174.45
 营业利润(元) 55,726,913.3827,850,550.96-905,308,255.43-95,111,622.5681,671,213.8757,656,812.87-320,323,915.53315,970,245.54228,347,559.03105,036,727.09
 利润总额(元) 48,269,601.8122,608,389.61-891,317,765.07-76,607,426.6280,269,881.1557,598,434.37-333,728,846.97315,975,902.43229,107,001.15106,033,488.83
 净利润(元) 47,088,035.8022,410,051.53-884,791,904.86-80,048,492.4276,672,046.5152,056,999.35-340,779,346.41293,579,284.48209,812,594.3598,247,987.79
 归属于母公司股东的净利润(元) 47,097,865.9322,420,230.99-884,772,394.21-80,044,079.4676,672,046.5152,056,999.35-340,779,346.41293,579,284.48209,812,594.3598,247,987.79
盈利能力:
 销售毛利率(%) 80.2679.1679.5381.0583.8086.9185.5686.1387.3987.04
 销售净利率(%) 10.7011.68-144.06-14.3817.0127.00-26.9532.4432.4436.57
 净资产收益率(%) 1.720.82-31.49-2.262.161.45----
 总资产报酬率ROA(%) 1.510.75-15.92-0.771.791.14----
 投入资本回报率ROIC(%) 1.110.52-18.77-1.531.451.01-6.945.834.331.98
营运能力:
 存货周转率(次) 0.450.220.800.550.420.14----
 应收账款周转率(次) 0.430.190.600.480.370.17----
 总资产周转率(次) 0.080.040.120.100.080.03----
偿债能力:
 资产负债率(%) 50.6151.4752.7445.7044.4141.1240.0831.3630.1632.58
 股东权益比率(%) 48.7547.9547.1654.3055.5958.8859.9268.6469.8467.42
 已获利息倍数(倍) 2.572.45-12.75-1.384.799.27-36.57-102.98259.6526.13
 流动比率 1.761.741.672.392.703.633.633.142.843.12
 速动比率 1.401.451.432.022.313.103.252.712.532.86
发展能力:
 营业收入增长率(%) -2.34-0.53-51.43-38.48-30.32-28.221.4626.6735.0630.39
 营业利润增长率(%) -31.77-51.70-182.62-130.10-64.23-45.11-190.3827.3435.2523.82
 税后利润增长率(%) -38.57-56.93-159.63-127.26-63.46-47.01-203.3525.2730.9325.22
 净资产增长率(%) -28.16-29.41-34.30-23.90-18.46-18.81-12.697.196.307.60
 总资产增长率(%) -18.09-13.32-16.53-3.792.44-7.026.8421.7521.8131.32

前瞻产业研究院